Marijuana visibly changes the brain, but to what functional effect?

Recent neuroimaging studies show that the use of pot causes changes in the corpus callosum, the brain’s largest white-matter structure, although the physical effect probably isn’t associated with psychosis. However, that’s not necessarily to say the lesions, imaged in the studies with diffusion tensor MR tractography, don’t cause or contribute to other mental-health problems.

Clarkson University biochemistry and proteomics researcher Alisa Woods, PhD, considers some of the relevant data and comments on it in Neurology Times.

As the legalization of marijuana continues expanding the drug’s medicinal and recreational use, Woods writes, individuals and mental-health workers can draw from the data to mull how much smoking or ingesting, if any, is safe or advisable:  

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.